Roche (SWX:ROP) Wins Priority Review For Gazyva And Launches First Automated HDV Test Simply Wall St 22:06 Wed, 15 Jul
FDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN Pharmaceutical Business Review 11:16 Wed, 15 Jul
FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy Business Wire (Press Release) 06:02 Wed, 15 Jul
